Purpose Corynebacterium spp. are Gram-positive bacteria commonly associated with the ocular surface. Corynebacterium mastitidis was isolated from mouse eyes and was demonstrated to induce a beneficial immune response that can protect the eye from pathogenic infection. Because eye-relevant Corynebacterium spp. are not well described, we generated a C. mast transposon (Tn) mutant library to gain a better understanding of the nature of eye-colonizing bacteria. Methods Tn mutagenesis was performed with a custom Tn5-based transposon that incorporated a promoterless gene for the fluorescent protein mCherry. We screened our library using flow cytometry and enzymatic assays to identify useful mutants that demonstrate the utility of our approach. Results Fluorescence-activated cell sorting (FACS) of mCherry + bacteria allowed us to identify a highly fluorescent mutant that was detectable on the murine ocular surface using microscopy. We also identified a functional knockout that was unable to hydrolyze urea, Urease KO . Although uric acid is an antimicrobial factor produced in tears, Urease KO bacterium maintained an ability to colonize the eye, suggesting that urea hydrolysis is not required for colonization. In vitro and in vivo, both mutants maintained the potential to stimulate protective immunity as compared to wild-type C. mast . Conclusions In sum, we describe a method to genetically modify an eye-colonizing microbe, C. mast. Furthermore, the procedures outlined here will allow for the continued development of genetic tools for modifying ocular Corynebacterium spp., which will lead to a more complete understanding of the interactions between the microbiome and host immunity at the ocular surface.
Recently, our lab discovered that the eye harbors a microbiome that includes Corynebacterium mastitidis, which induces the recruitment of gdT cells and the production of interleukin 17 (IL-17). This local immune response to C. mast can protect the eye from more serious infections, such as Candida albicans and Pseudomonas aeruginosa. Because of C. mast’s ability to stably colonize the ocular surface while inducing a beneficial immune response, we believe that this bacterium has the potential to act as a natural vehicle to deliver therapeutics locally at the ocular surface to alleviate ocular surface disease. Before this can become a reality, a reliable method to genetically modify C. mast is required. Therefore, we took the initial steps toward achieving this goal by genetically modifying C. mast to express genes of interest using transposon mutagenesis. This allowed us to create a mutant library with 1,000+ distinct candidates that expressed the fluorescent protein, mCherry, and kanamycin resistance. Using FACS, we were able to select the brightest C. mast mutants. The brightest four mutants were used to inoculate the eyes of C57BL/6 mice, so that we could: 1) track C. mast in vivo and 2) ensure that the promoters upstream of the genes of interest remain active when C. mast has colonized the ocular mucosa. We were able to image recombinant bacteria directly ex vivo and also confirmed that there was no decrease in bacterial fitness or the protective immune response elicited by C. mast. We concluded from these studies that C. mast can be engineered to express proteins of interest without a reduction in bacterial fitness or protective immunity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.